Search citation statements
Paper Sections
Citation Types
Year Published
Publication Types
Relationship
Authors
Journals
Breast cancer poses a significant threat to women’s health, emphasizing the crucial role of timely detection. Traditional pathology reports, though widely used, face challenges prompting the development of automated Deep Learning (DL) tools. DL models, gaining traction in radiology, offer precise diagnoses; however, issues with generalization on varying dataset sizes persist. This paper introduces a computationally efficient DL framework, addressing dataset imbalance through a hybrid model design, ensuring both accuracy and speed in breast cancer image classification. Proposed model novel design excels in accuracy and generalization across medical imaging datasets, providing a robust tool for precise diagnostics. The proposed model integrates features from two classifiers, Inception ResNet V2 and Vision Transformers (ViT), to enhance the classification of breast cancer. This synergistic blend enhances adaptability, ensuring consistent performance across diverse dataset scales. A key contribution is the introduction of an Efficient Attention Mechanism within one of the classifiers, optimizing focus on critical features for improved accuracy and computational efficiency. Further, a Resource-Efficient Optimization model through feature selection is proposed, streamlining computational usage without compromising accuracy. Addressing the inherent heterogeneity within classifiers, our framework integrates high dimensional features comprehensively, leading to more accurate tumor class predictions. This consideration of heterogeneity marks a significant leap forward in precision for breast cancer diagnosis. An extensive analysis on datasets, BreakHis and BACH, that are imbalanced in nature is conducted by evaluating complexity, performance, and resource usage. Comprehensive evaluation using the datasets and standard performance metrics accuracy, precision, Recall, F1-score, MCC reveals the model’s high efficacy, achieving a testing accuracy of 0.9936 and 0.994, with precision, recall, F1-score and MCC scores of 0.9919, 0.987, 0.9898, 0.9852 and 0.989, 1.0, 0.993, 0.988 on the BreakHis and BACH datasets, respectively. Our proposed model outperforms state-of-the-art techniques, demonstrating superior accuracy across different datasets, with improvements ranging from 0.25% to 15% on the BACH dataset and from 0.36% to 15.02% on the BreakHis dataset. Our results position the framework as a promising solution for advancing breast cancer prediction in both clinical and research applications. The collective contributions, from framework and hybrid model design to feature selection and classifier heterogeneity consideration, establish a holistic and state-of-the-art approach, significantly improving accuracy and establishing optimization in breast cancer classification from MRI images. Future research for the DL framework in breast cancer image classification includes enhancing interpretability, integrating multi-modal data, and developing personalized treatments.
Breast cancer poses a significant threat to women’s health, emphasizing the crucial role of timely detection. Traditional pathology reports, though widely used, face challenges prompting the development of automated Deep Learning (DL) tools. DL models, gaining traction in radiology, offer precise diagnoses; however, issues with generalization on varying dataset sizes persist. This paper introduces a computationally efficient DL framework, addressing dataset imbalance through a hybrid model design, ensuring both accuracy and speed in breast cancer image classification. Proposed model novel design excels in accuracy and generalization across medical imaging datasets, providing a robust tool for precise diagnostics. The proposed model integrates features from two classifiers, Inception ResNet V2 and Vision Transformers (ViT), to enhance the classification of breast cancer. This synergistic blend enhances adaptability, ensuring consistent performance across diverse dataset scales. A key contribution is the introduction of an Efficient Attention Mechanism within one of the classifiers, optimizing focus on critical features for improved accuracy and computational efficiency. Further, a Resource-Efficient Optimization model through feature selection is proposed, streamlining computational usage without compromising accuracy. Addressing the inherent heterogeneity within classifiers, our framework integrates high dimensional features comprehensively, leading to more accurate tumor class predictions. This consideration of heterogeneity marks a significant leap forward in precision for breast cancer diagnosis. An extensive analysis on datasets, BreakHis and BACH, that are imbalanced in nature is conducted by evaluating complexity, performance, and resource usage. Comprehensive evaluation using the datasets and standard performance metrics accuracy, precision, Recall, F1-score, MCC reveals the model’s high efficacy, achieving a testing accuracy of 0.9936 and 0.994, with precision, recall, F1-score and MCC scores of 0.9919, 0.987, 0.9898, 0.9852 and 0.989, 1.0, 0.993, 0.988 on the BreakHis and BACH datasets, respectively. Our proposed model outperforms state-of-the-art techniques, demonstrating superior accuracy across different datasets, with improvements ranging from 0.25% to 15% on the BACH dataset and from 0.36% to 15.02% on the BreakHis dataset. Our results position the framework as a promising solution for advancing breast cancer prediction in both clinical and research applications. The collective contributions, from framework and hybrid model design to feature selection and classifier heterogeneity consideration, establish a holistic and state-of-the-art approach, significantly improving accuracy and establishing optimization in breast cancer classification from MRI images. Future research for the DL framework in breast cancer image classification includes enhancing interpretability, integrating multi-modal data, and developing personalized treatments.
Breast cancer remains a significant health concern globally, with early detection being crucial for effective treatment. In this study, we explore the predictive power of various diagnostic features in breast cancer using machine learning techniques. We analyzed a dataset comprising clinical measurements of mammograms from 569 patients, including mean radius, texture, perimeter, area, and smoothness, alongside the diagnosis outcome. Our methodology involves preprocessing steps such as handling missing values and removing duplicates, followed by a correlation analysis to identify and eliminate highly correlated features. Subsequently, we train eight machine learning models, including Logistic Regression (LR), K-Nearest Neighbors (K-NN), Linear Support Vector Machine (SVM), Kernel SVM, Naïve Bayes, Decision Trees Classifier (DTC), Random Forest Classifier (RFC), and Artificial Neural Networks (ANN), to predict the diagnosis based on the selected features. Through comprehensive evaluation metrics such as accuracy and confusion matrices, we assess the performance of each model. Our findings reveal promising results, with 6 out of 8 models achieving high accuracy (>90%), with ANN having the highest accuracy in diagnosing breast cancer based on the selected features. These results underscore the potential of machine learning algorithms in aiding early breast cancer diagnosis and highlight the importance of feature selection in improving predictive performance.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.